Safety is the expectation for Ph1 clinical trial and any efficacy seen has exceed expectation as this is usually seen in Ph2 clinical trial, LC has mentioned the purpose of Ph1 clinical trial even in the ASX announcement.
- Forums
- ASX - By Stock
- Media Thread
IMU
imugene limited
Add to My Watchlist
0.00%
!
1.1¢

Safety is the expectation for Ph1 clinical trial and any...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.13M |
Open | High | Low | Value | Volume |
1.1¢ | 1.2¢ | 1.1¢ | $338.0K | 30.69M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 3480808 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 10994115 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 3480808 | 0.011 |
107 | 27410672 | 0.010 |
35 | 16158780 | 0.009 |
14 | 4310247 | 0.008 |
7 | 3365713 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 10994115 | 28 |
0.013 | 7916193 | 26 |
0.014 | 8302051 | 33 |
0.015 | 8094214 | 28 |
0.016 | 6615871 | 27 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online